Board of Directors
Wenseng “Wendy” Pan is a partner in Goodwin’s Life Sciences group, focusing on mergers and acquisitions, technology-based transactions and strategic collaborations primarily in the life sciences industry and in cross-border settings. She has advised private equity firms in leveraged buyouts and has represented companies in the financial, technology, media and telecom, biopharmaceutical, manufacturing, publishing, electronics, and retail sectors in stock and cash acquisitions, mergers, tender offers and going-private transactions. She also represents venture capital firms and startup and growth-stage companies in venture capital and pre-IPO financings. As a former scientist and a registered U.S. patent lawyer, Ms. Pan is uniquely positioned to counsel clients on intellectual property issues in non-contentious settings. She has advised life sciences and technology companies in structuring and negotiating complex IP-based transactions and other commercial arrangements, including product and technology licensing, strategic partnerships and joint venture formations, research, product development and commercialization collaborations, as well as mergers and acquisitions and private investments. Prior to joining Goodwin in 2019, Ms. Pan was a partner at Sidley Austin LLP. She is fluent in Mandarin Chinese and English.

Emerging Opportunities in Global Markets

11:45 AM–5:00 PM Jun 4, 2018 (US - Eastern)

Room 253ABC, Level 2

Katherine AndersenHead of Healthcare Corporate Finance and East/Central Life Science atSilicon Valley Bank Mr. Michael ChanSenior Vice President atHong Kong Exchanges and Clearing Limited (HKEX) Helen ChenManaging Director, Head of L.E.K. China and Asia Life Sciences atL.E.K. Consulting Tony ChenPartner atJones Day Shanghei Joseph DamondExecutive Vice President, International Affairs atBiotechnology Innovation Organization Yuan-Hua DingExecutive Director and Head of External Science & Innovation atPfizer Inc. Monica H.Director, International Affairs atBiotechnology Innovation Organization Edward HuChief Financial Officer and Chief Investment Officers atWuXi AppTec Kewen JinManaging Partner atSerica Partners Alex JungPartner/Managing DIrector atEY-Parthenon Wei LiFounding Partner at6 Dimensions Capital Micah MackisonSenior VP for Corporate Development and Strategy atAssembly Biosciences Wendy PanBoard of Directors atBayHelix Donghui QinDirector of Innovation atFerring Pharmaceuticals Greg ScottFounder and Chairman atChinaBIO Group Victor ShiChairman atBayHelix Alan TurleyDeputy Assistant Secretary for China atU.S. Department of Commerce Jonathan WangSenior VP and Head of Business Development atZai Lab Lijun WuChief Scientific Officer and Senior VP R&D, Fosun Pharma USA atShanghai Henlius Biotech Haishan XiongSenior Vice President for Business Development atFountain Medical Development GE YanfengDirector-General of the Research Department of Social Development atDevelopment Research Center of the State Council (DRC) Debra YuManaging Director atChina Renaissance Securities (US) Inc.
None yet.